Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib and Trastuzumab in Older Adults With HER2+ Advanced Breast Cancer
NCT01273610Phase 2Active, not recruiting
- Sponsor
- City of Hope
- Start
- Apr 2011
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib, trastuzumab in breast cancer, sponsored by City of Hope. Started Apr 2011; status: active, not recruiting.
02
Drugs
lapatinibtrastuzumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01273610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01273610.